Markowski, M. C., Taplin, M., Aggarwal, R., Sena, L. A., Wang, H., Qi, H., . . . Antonarakis, E. S. (2024, January). Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: The COMBAT phase II trial. Nature Communications.
Chicago Style (17th ed.) CitationMarkowski, Mark C., et al. "Bipolar Androgen Therapy Plus Nivolumab for Patients with Metastatic Castration-resistant Prostate Cancer: The COMBAT Phase II Trial." Nature Communications Jan. 2024.
MLA (9th ed.) CitationMarkowski, Mark C., et al. "Bipolar Androgen Therapy Plus Nivolumab for Patients with Metastatic Castration-resistant Prostate Cancer: The COMBAT Phase II Trial." Nature Communications, Jan. 2024.
Warning: These citations may not always be 100% accurate.
